Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LYB001
BIOLOGICAL
4 trials
Sponsors
Yantai Patronus Biotech Co., Ltd.
, Guangzhou Patronus Biotech Co., Ltd.
Conditions
COVID-19
Vaccine Reaction
Early Phase 1
The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001
NCT05928455
Guangzhou Patronus Biotech Co., Ltd.
COVID-19, Vaccine Reaction
Start: 2022-05-14
End: 2023-06-30
Updated: 2023-07-03
Phase 1
A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001
NCT05125926
Yantai Patronus Biotech Co., Ltd.
COVID-19
Start: 2021-12-31
End: 2023-04-30
Target: 100
Updated: 2021-11-18
Phase 2
Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001
NCT05137444
Yantai Patronus Biotech Co., Ltd.
COVID-19
Start: 2022-01-31
End: 2023-05-31
Target: 1900
Updated: 2021-11-30
The Phase Ⅱ/Ⅲ Trial of LYB001
NCT05602558
Yantai Patronus Biotech Co., Ltd.
COVID-19
Start: 2022-12-31
End: 2024-02-29
Target: 18000
Updated: 2022-11-02